Mini Review - Journal of Mental Health and Aging (2024) Volume 8, Issue 3
Polypharmacy in older adults: Understanding the risks and solution
Ben Ju*Network Aging Research, Heidelberg University, Bergheimer Straße 20, 69115 Heidelberg, Germany
- *Corresponding Author:
- Ben Ju
Network Aging Research, Heidelberg University
Bergheimer Straße 20, 69115 Heidelberg, Germany
E-mail: benju@Dkfz-Heidelberg.de
Received: 09-May-2024, Manuscript No. AAJMHA-24-132426; Editor assigned: 13- May -2024, Pre QC No. AAJMHA-24-132426 (PQ); Reviewed: 25- May -2024, QC No. AAJMHA-24-132426; Revised: 28- May -2024, Manuscript No. AAJMHA-24-132426 (R); Published: 31- May -2024, DOI: 10.35841/aajmha-8.3.210
Citation: Ju B. Polypharmacy in older adults: Understanding the risks and solution. J Ment Health Aging. 2024; 8(3)210
Introduction
As individuals age, the management of multiple health conditions often becomes a complex challenge. It's not uncommon for older adults to find themselves juggling a variety of medications prescribed for various ailments. While these medications are intended to improve health and quality of life, the phenomenon of polypharmacy—defined as the concurrent use of multiple medications—is becoming increasingly prevalent among seniors, bringing with it a host of potential risks and complications [1,2].
Understanding Polypharmacy
Polypharmacy occurs when an individual is prescribed or takes multiple medications concurrently, typically defined as five or more medications. This phenomenon is particularly common among older adults due to the higher prevalence of chronic health conditions and age-related physiological changes. While each medication may be prescribed with good intentions to manage specific health issues, the cumulative effects of multiple drugs can lead to unintended consequences [3].
Risks and Complications
Polypharmacy poses several risks and complications for older adults:
1. Adverse Drug Reactions (ADRs): Taking multiple medications increases the risk of adverse drug reactions, which can range from mild side effects to severe complications. Older adults are more susceptible to ADRs due to age-related changes in metabolism and organ function.
2. Drug-Drug Interactions: When multiple medications are taken together, there is a greater likelihood of drug-drug interactions, where one medication affects the absorption, metabolism, or elimination of another. These interactions can lead to reduced efficacy or increased toxicity of one or more drugs.
3. Increased Fall Risk: Certain medications, such as sedatives, anticholinergics, and psychotropic drugs, can impair balance and coordination, increasing the risk of falls and related injuries among older adults.
4. Cognitive Impairment: Some medications have been associated with cognitive side effects, including confusion, memory impairment, and delirium, particularly in older adults with preexisting cognitive vulnerabilities.
5. Nonadherence: Managing multiple medications can be overwhelming for older adults, leading to nonadherence or improper medication management practices, such as skipping doses or taking medications at incorrect times [4-7].
Strategies for Prevention and Management
Preventing and managing polypharmacy requires a multifaceted approach involving healthcare providers, patients, caregivers, and healthcare systems. Here are some strategies to consider:
1. Medication Review: Regular medication reviews by healthcare providers are essential to assess the appropriateness, necessity, and effectiveness of each medication. This process involves reconciling medication lists, identifying potential drug-drug interactions, and deprescribing unnecessary or potentially harmful medications.
2. Deprescribing: Deprescribing involves systematically discontinuing medications that are no longer necessary, beneficial, or appropriate for the individual. This process requires careful consideration of each medication's risks and benefits, as well as the patient's goals of care and preferences.
3. Simplification: Simplifying medication regimens by consolidating dosing schedules, reducing the number of medications, and utilizing combination products can help streamline medication management for older adults.
4. Patient Education: Educating older adults and their caregivers about the importance of medication adherence, potential side effects, and proper medication management techniques can empower them to take an active role in their healthcare.
5. Multidisciplinary Collaboration: Collaboration among healthcare providers, including physicians, pharmacists, nurses, and other allied health professionals, is essential to optimize medication therapy and minimize the risks associated with polypharmacy.
6. Regular Monitoring: Ongoing monitoring of medication therapy, including routine laboratory tests, clinical assessments, and medication reconciliation, is necessary to detect and address potential problems related to polypharmacy [8-10].
Conclusion
Polypharmacy is a complex and multifaceted issue that poses significant challenges for older adults, healthcare providers, and caregivers alike. By understanding the risks and implementing proactive strategies for prevention and management, we can minimize the potential harms associated with polypharmacy and optimize medication therapy to improve the health and well-being of older adults. Effective communication, shared decision-making, and individualized care are essential components of a comprehensive approach to addressing polypharmacy in the aging population.
References
- Keefer L, Kane SV. Considering The Bidirectional Pathways Between Depression And IBD: Recommendations For Comprehensive IBD Care. J Gastroenterol Hepatol. 2017;13(3):164.
- Chen PC, Chan YT, Chen HF. Population-Based Cohort Analyses Of The Bidirectional Relationship Between Type 2 Diabetes And Depression. Diabetes care. 2013;36(2):376-82.
- Golden SH, Lazo M, Carnethon M. Examining A Bidirectional Association Between Depressive Symptoms And Diabetes. Jama. 2008;299(23):2751-9.
- Pan A, Lucas M, Sun Q. Bidirectional Association Between Depression And Type 2 Diabetes Mellitus In Women. Arch Intern Med. 2010;170(21):1884-91.
- Atlantis E, Sullivan T. Bidirectional Association Between Depression And Sexual Dysfunction: A Systematic Review And Meta-Analysis. J Sex Med. 2012;9(6):1497-507.
- Pan A, Keum N, Okereke OI. Bidirectional Association Between Depression And Metabolic Syndrome: A Systematic Review And Meta-Analysis Of Epidemiological Studies. Diabetes care. 2012;35(5):1171-80.
- Sivertsen B, Salo P, Mykletun A. The Bidirectional Association Between Depression And Insomnia: The HUNT Study. Psychosom Med. 2012;74(7):758-65.
- Hurvitz EA, Whitney DG, Waldron-Perrine B. Navigating The Pathway To Care In Adults With Cerebral Palsy. Front Neurol. 2021;12:734139.
- O'Brien EM, Waxenberg LB, Atchison JW. Intraindividual Variability In Daily Sleep And Pain Ratings Among Chronic Pain Patients: Bidirectional Association And The Role Of Negative Mood. Clin J Pain. 2011;27(5):425-33.
- Choi KW, Chen CY, Stein MB. Assessment Of Bidirectional Relationships Between Physical Activity And Depression Among Adults: A 2-Sample Mendelian Randomization Study. JAMA Psychiatry. 2019;76(4):399-408.
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref